Moderna says its COVID-19 vaccine has not led to blood clots following J&J reports

Shawna Chen
·1 min read

Moderna released a statement Tuesday reassuring people of the safety of its coronavirus vaccine hours after the FDA recommended pausing the administration Johnson & Johnson (J&J) vaccines due to reported cases of "extremely rare" blood clots.

What they're saying: After over 64.5 million doses administered globally, a comprehensive assessment using data through March 22 "does not suggest an association with" blood clots in the brain or veins, Moderna said.

Get market news worthy of your time with Axios Markets. Subscribe for free.

The big picture: The Centers for Disease Control and FDA made its recommendation on the J&J shot "out of an abundance of caution" after six women developed blood clots within two weeks of receiving the shot.

  • J&J delayed rollout of its vaccine in Europe after the FDA announcement.

More from Axios: Sign up to get the latest market trends with Axios Markets. Subscribe for free